Tenderwize
Back to tender search

Open-house rebate agreements for Tocilizumab

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Nov 05, 2026 · 80 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tocilizumab, ATC L04AC07

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

52 / 100

Complexity

58 / 100

Risk factors

Paper submissions require two original signed copies and timely receipt of the originals by the 10th of the month after...

Participation is limited to pharmaceutical companies and requires a signed declaration of reliability.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Dec 2026
  • Non-exclusive supply/rebate agreement for Tocilizumab, ATC L04AC07.
  • Open-house model with identical, non-individually negotiable contract terms.
Show full summary

This is an open-house pharmaceutical supply arrangement for Tocilizumab (ATC L04AC07) offered by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement can join on identical, non-negotiable terms. The contract can start from 2025-01-01, runs until 2026-12-31, and applications can be submitted until 2026-11-05 11:00. No contract value is stated.

Risks

Paper submissions require two original signed copies and timely receipt of the originals by the 10th of the month after...

Participation is limited to pharmaceutical companies and requires a signed declaration of reliability.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreements for Tocilizumab

Single lot covering non-exclusive open-house rebate agreements for the pharmaceutical product Tocilizumab, ATC L04AC07. The lot is for supplies in Germany, with performance in Bavaria (DE212). The procedure is open-house, with no selection among bidders and identical contract terms for all eligible pharmaceutical companies. Lot information comes from structured data and the XML notice.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Dec 2024 - Dec 2026

Category

Pharmaceutical products

Deadline

Deadline Nov 05, 2026

Procurement Details

Publication date
17 Nov 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
701022-2024

Documents (2)

Similar tenders